These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16242696)

  • 1. The association of microalbuminuria with clinical cardiovascular disease and subclinical atherosclerosis in the elderly: the Cardiovascular Health Study.
    Cao JJ; Barzilay JI; Peterson D; Manolio TA; Psaty BM; Kuller L; Wexler J; Bleyer AJ; Cushman M
    Atherosclerosis; 2006 Aug; 187(2):372-7. PubMed ID: 16242696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study.
    Pearte CA; Furberg CD; O'Meara ES; Psaty BM; Kuller L; Powe NR; Manolio T
    Circulation; 2006 May; 113(18):2177-85. PubMed ID: 16651468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined role of reduced estimated glomerular filtration rate and microalbuminuria on the prevalence of peripheral arterial disease.
    Baber U; Mann D; Shimbo D; Woodward M; Olin JW; Muntner P
    Am J Cardiol; 2009 Nov; 104(10):1446-51. PubMed ID: 19892066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes.
    Ingelsson E; Sullivan LM; Murabito JM; Fox CS; Benjamin EJ; Polak JF; Meigs JB; Keyes MJ; O'Donnell CJ; Wang TJ; D'Agostino RB; Wolf PA; Vasan RS
    Diabetes; 2007 Jun; 56(6):1718-26. PubMed ID: 17369522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carotid Atherosclerosis, Microalbuminuria, and Estimated 10-Year Atherosclerotic Cardiovascular Disease Risk in Sub-Saharan Africa.
    Nonterah EA; Boateng D; Crowther NJ; Klipstein-Grobusch K; Oduro AR; Agongo G; Mohamed SF; Boua PR; Choma SSR; Norris SA; Tollman SM; Bots ML; Ramsay M; Grobbee D
    JAMA Netw Open; 2022 Apr; 5(4):e227559. PubMed ID: 35471573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ideal cardiovascular health: associations with biomarkers and subclinical disease and impact on incidence of cardiovascular disease in the Framingham Offspring Study.
    Xanthakis V; Enserro DM; Murabito JM; Polak JF; Wollert KC; Januzzi JL; Wang TJ; Tofler G; Vasan RS
    Circulation; 2014 Nov; 130(19):1676-83. PubMed ID: 25274000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: the Cardiovascular Health Study.
    Barzilay JI; Spiekerman CF; Kuller LH; Burke GL; Bittner V; Gottdiener JS; Brancati FL; Orchard TJ; O'Leary DH; Savage PJ;
    Diabetes Care; 2001 Jul; 24(7):1233-9. PubMed ID: 11423508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of microalbuminuria in patients with the metabolic syndrome to predict subclinical atherosclerosis and cardiovascular disease outcomes.
    Afonso L; Hari P; Kondur A; Veeranna V; Manickam P; Simegn M; Jacob S; Ference B
    Am J Cardiol; 2010 Oct; 106(7):976-83. PubMed ID: 20854960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group.
    Newman AB; Siscovick DS; Manolio TA; Polak J; Fried LP; Borhani NO; Wolfson SK
    Circulation; 1993 Sep; 88(3):837-45. PubMed ID: 8353913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between C-reactive protein level and peripheral arterial disease among US adults without cardiovascular disease, diabetes, or hypertension.
    Shankar A; Li J; Nieto FJ; Klein BE; Klein R
    Am Heart J; 2007 Sep; 154(3):495-501. PubMed ID: 17719297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of site and extent of clinically evident cardiovascular disease and atherosclerotic burden on new cardiovascular events in patients with Type 2 diabetes. The SMART study.
    Gorter PM; Visseren FL; Algra A; van der Graaf Y;
    Diabet Med; 2007 Dec; 24(12):1352-60. PubMed ID: 18042079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical atherosclerosis and associated risk factors among HIV-infected adults in Jos, North Central Nigeria: a cross-sectional study.
    Imoh LC; Ani CC; Iyua KO; Odo AI; Amusa GA; Osaigbovo GO; Isichei CO; Agbaji OO; Imade G; Zoakah AI; Okeahialam BN; Sagay AS
    Pan Afr Med J; 2020; 37():388. PubMed ID: 33796201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators.
    Gerstein HC; Mann JF; Pogue J; Dinneen SF; Hallé JP; Hoogwerf B; Joyce C; Rashkow A; Young J; Zinman B; Yusuf S
    Diabetes Care; 2000 Apr; 23 Suppl 2():B35-9. PubMed ID: 10860189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence and risk factors of retinal microvascular abnormalities in older persons: The Cardiovascular Health Study.
    Wong TY; Klein R; Sharrett AR; Manolio TA; Hubbard LD; Marino EK; Kuller L; Burke G; Tracy RP; Polak JF; Gottdiener JS; Siscovick DS
    Ophthalmology; 2003 Apr; 110(4):658-66. PubMed ID: 12689883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced chronic kidney disease, cardiovascular events and the effect of diabetes: data from the Atherosclerosis and Folic Acid Supplementation Trial.
    Zoungas S; Lui M; Kerr PG; Teede HJ; McNeil JJ; McGrath BP; Polkinghorne KR
    Intern Med J; 2011 Dec; 41(12):825-32. PubMed ID: 20298505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey.
    Jones CA; Francis ME; Eberhardt MS; Chavers B; Coresh J; Engelgau M; Kusek JW; Byrd-Holt D; Narayan KM; Herman WH; Jones CP; Salive M; Agodoa LY
    Am J Kidney Dis; 2002 Mar; 39(3):445-59. PubMed ID: 11877563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of cardio-metabolic risk profile in patients with psoriasis.
    Karoli R; Fatima J; Shukla V; Dhillon KS; Khanduri S; Maini S; Chandra A
    J Assoc Physicians India; 2013 Nov; 61(11):798-803. PubMed ID: 24974491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Egypt Information, Prevention, and Treatment of Chronic Kidney Disease (EGIPT-CKD) programme: prevalence and risk factors for microalbuminuria among the relatives of patients with CKD in Egypt.
    Gouda Z; Mashaal G; Bello AK; El Attar A; El Kemmry T; El Reweny A; El Nahas M
    Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):1055-63. PubMed ID: 21912051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of dietary protein intake and microalbuminuria in healthy adults: Third National Health and Nutrition Examination Survey.
    Wrone EM; Carnethon MR; Palaniappan L; Fortmann SP;
    Am J Kidney Dis; 2003 Mar; 41(3):580-7. PubMed ID: 12612981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome.
    Esteghamati A; Abbasi M; Nakhjavani M; Yousefizadeh A; Basa AP; Afshar H
    Cardiovasc Diabetol; 2006 Jul; 5():15. PubMed ID: 16842631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.